BEDSIDE ACTION BOX — Two Interventions, Big Impact
- Antenatal corticosteroids accelerate fetal lung maturation and cut RDS, IVH, NEC, and neonatal death — the single most effective intervention for threatened preterm birth.
- Magnesium sulfate given before early preterm delivery reduces cerebral palsy — a neuroprotectant, not a lung drug.
- Know what the mother received and when: steroid benefit peaks >24 hours to <7 days after the course.
- At delivery, expect the magnesium-exposed infant to be hypotonic or apneic — be ready to support breathing.
- Neither intervention replaces good delivery-room stabilization and NRP.
1. Overview
The Two Interventions
Two antenatal treatments have robust randomized evidence for improving preterm outcomes and are worth understanding as a neonatal provider. A single course of antenatal corticosteroids matures the fetal lung and reduces several major morbidities and death. Magnesium sulfate, given to the mother when very preterm birth is imminent, reduces the risk and severity of cerebral palsy in the surviving child.
Why This Topic Matters
These are the highest-yield "before the baby arrives" interventions on the boards and at the bedside. Knowing their windows, benefits, and neonatal side effects lets you anticipate the newborn's course from the maternal history alone.
2. Who These Apply To
Scope
- Corticosteroids: anticipated preterm birth, classically 24⁰⁄₇–33⁶⁄₇ weeks, with benefit extending into the late-preterm period in selected cases.
- Magnesium neuroprotection: anticipated early preterm birth, commonly <32 weeks (thresholds vary by protocol).
- Cross-references: RDS/surfactant (6.1); IVH (9.2); cerebral palsy/PVL (9.4); preeclampsia (13.2).
3. Antenatal Corticosteroids
Betamethasone or dexamethasone given to the mother crosses the placenta and drives type II pneumocyte maturation and surfactant production, alongside broader effects that stabilize the preterm infant.
What They Do
- Accelerate fetal lung maturation → less respiratory distress syndrome.
- Reduce intraventricular hemorrhage, necrotizing enterocolitis, and neonatal mortality.
- Improve circulatory stability and response to postnatal surfactant.
4. Magnesium Sulfate — Neuroprotection
Given to the mother shortly before anticipated very preterm delivery, magnesium sulfate reduces cerebral palsy in survivors. The exact mechanism is not fully settled but likely involves reduced excitotoxicity and stabilization of cerebral blood flow in the vulnerable preterm brain.
What It Does
- Reduces the risk and severity of cerebral palsy (number needed to treat roughly 60 to prevent one case, from the BEAM and related trials).
- It is a neuroprotectant — it does not mature the lungs and is not a substitute for steroids.
5. Timing & Dosing (Obstetric)
| Intervention | Typical regimen | Timing note |
|---|
| Betamethasone | 12 mg IM, two doses 24 hours apart | Peak benefit >24 h to <7 days after the course |
| Dexamethasone | 6 mg IM, four doses 12 hours apart | Equivalent efficacy to betamethasone |
| Rescue course | A single repeat course may be considered | If <34 weeks, >7–14 days since the first course, and delivery again imminent |
| Magnesium sulfate | Loading dose then infusion per protocol | Given close to anticipated early preterm delivery |
Verify Locally
Gestational-age windows, repeat-course criteria, and magnesium regimens vary by guideline and institution — always confirm against your maternity protocol.
6. Benefits at a Glance
| Outcome | Corticosteroids | Magnesium |
|---|
| Respiratory distress syndrome | Reduced | No effect |
| Intraventricular hemorrhage | Reduced | No consistent effect |
| Necrotizing enterocolitis | Reduced | No effect |
| Neonatal mortality | Reduced | No significant change |
| Cerebral palsy | Not the primary effect | Reduced |
7. Neonatal Effects to Anticipate
At the Bedside
- Magnesium: hypotonia, respiratory depression/apnea, poor feeding, and rarely hypermagnesemia — anticipate at delivery and monitor.
- Corticosteroids: transient neonatal hyperglycemia can occur; repeated or excessive courses are associated with lower birth weight, which is why single courses are preferred.
- A steroid-exposed, magnesium-exposed preterm infant is generally more stable but may be floppy in the first day.
8. Monitoring
What to Track
- Respiration and tone in the magnesium-exposed infant until the effect resolves (usually 24–72 hours).
- Glucose, given both prematurity and possible steroid-related hyperglycemia.
- Feeding progress and the usual preterm surveillance.
9. Contraindications & Precautions
Safety Cautions
- Do not treat magnesium as a lung-maturation drug — it does not replace corticosteroids.
- Do not assume steroids eliminate the need for delivery-room stabilization, surfactant, or NRP.
- Avoid attributing all neonatal hypotonia/apnea to magnesium before excluding sepsis, hypoglycemia, and hypoxic injury.
- Repeated steroid courses beyond a single rescue are discouraged (reduced growth).
10. Escalation & Follow-Up
Escalate When…
- Respiratory depression persists beyond the expected magnesium window.
- Unexpected instability that isn't explained by prematurity alone.
Follow-Up
- Very preterm infants enter neurodevelopmental follow-up regardless of magnesium exposure.
- Document antenatal steroid and magnesium exposure clearly in the neonatal record.
11. Key Pearls
High-Value Clinical Pearls
- Steroids = lungs (and IVH, NEC, mortality). Magnesium = brain (cerebral palsy). Keep the two effects separate in your mind.
- Steroid benefit is greatest >24 hours to <7 days after the course.
- Magnesium's neonatal signature is a floppy, apneic baby that recovers over a day or two.
- A single course of steroids is preferred; one rescue course may be justified.
- Both are maternal treatments with fetal benefit — they never replace resuscitation and NRP.
12. Common Mistakes to Avoid
Pitfalls & Better Practice
Frequent misconceptions about antenatal steroids and magnesium.
| Mistake | Why it's wrong | Better understanding |
|---|
| Thinking magnesium matures the lungs. | It is a neuroprotectant. | Steroids mature lungs; magnesium protects the brain. |
| Blaming all neonatal apnea on magnesium. | Misses sepsis/hypoglycemia/hypoxia. | Exclude other causes first. |
| Giving multiple steroid courses freely. | Reduces birth weight. | Single course; at most one rescue. |
| Assuming steroids remove the need for surfactant. | Preterm lungs may still need it. | Treat the infant's actual respiratory status. |
13. Board-Style High-Yield Summary
Key Takeaways
- Antenatal corticosteroids (betamethasone/dexamethasone) reduce RDS, IVH, NEC, and neonatal death — the top intervention for threatened preterm birth.
- Benefit window: >24 hours to <7 days after the course; single course preferred, one rescue possible.
- Magnesium sulfate before early preterm birth reduces cerebral palsy (NNT ≈ 60); it is neuroprotection, not lung maturation.
- Neonatal magnesium effect: hypotonia, apnea, poor feeding — transient and supportive.
- Neither replaces delivery-room stabilization, surfactant, or NRP.
14. References
- 1.American College of Obstetricians and Gynecologists. Antenatal Corticosteroid Therapy for Fetal Maturation. ACOG Committee Opinion.
- 2.Roberts D, et al. Antenatal corticosteroids for accelerating fetal lung maturation. Cochrane Database Syst Rev.
- 3.Doyle LW, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev.
- 4.Rouse DJ, et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy (BEAM). N Engl J Med. 2008;359:895–905.
- 5.Baylor College of Medicine, Division of Neonatology. Guidelines for Acute Care of the Neonate, Edition 33, 2025–2026.
Back to Clinical Guideline Hubs